Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
SGQ 0.300 +0.0% AMCO 0.250 +0.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.910 +0.0% SMY 0.235 +0.0% SAG 1.02 +0.0% NTH 0.165 +0.0% PEMC 0.045 +0.0% NAR 0.180 +0.0% ARG 6.99 +0.0% VMXX 0.970 +0.0% ABRA 14.01 +0.0% LAF 1.63 +0.0% AMX 4.14 +0.0% SGQ 0.300 +0.0% AMCO 0.250 +0.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.910 +0.0% SMY 0.235 +0.0% SAG 1.02 +0.0% NTH 0.165 +0.0% PEMC 0.045 +0.0% NAR 0.180 +0.0% ARG 6.99 +0.0% VMXX 0.970 +0.0% ABRA 14.01 +0.0% LAF 1.63 +0.0% AMX 4.14 +0.0%
Financings

Trulieve Completes Redemption of All US$368 Million 8.0% Senior Secured Notes due 2026

By The Northwire Desk — AI Analysis Dec 08, 2025 · 08:00 TRUL · 8.42 Trulieve Cannabis Corp.
TRUL · Price

Executive Summary

  • Trulieve Cannabis Corp. completed the full redemption of its US$368 million 8.0% senior secured notes due 2026.
  • Approximately US$373 million in cash was used, covering principal and accrued interest up to the redemption date (December 5, 2025).
  • The notes were delisted from the Canadian Securities Exchange as of December 5, 2025.

Key Details

  • Redemption amount: US$368,000,000 principal.
  • Cash outlay: Approximately US$373,000,000 (principal plus accrued/unpaid interest).
  • Interest rate on notes: 8.0% senior secured.
  • Maturity date of original notes: 2026.
  • Redemption date: December 5, 2025 (cash paid through that date).
  • CUSIP/ISIN: CUSIP 89788CAD6 / ISIN CA89788CAD61.
  • Trading symbol prior to redemption: TRUL.NT.U on the Canadian Securities Exchange.
  • Delisting: Notes ceased trading and were delisted as of December 5, 2025.
  • Additional information source: Odyssey Trust Company (provides further details on the redemption).

Notable Quotes

(No executive quotes included in the release.)

Read the original news release →

More from Trulieve Cannabis Corp.

Jul 01, 2026 · 08:10

Georgia expansion marks first sales, but revenue compression and margin pressure remain key headwinds.

Production / Operations Jun 09, 2026 · 08:00

Trulieve's $50M Buyback Signals Confidence, But 43% Run-Up Into the Print Caps Near-Term Upside

Other Jun 05, 2026 · 07:00

Trulieve’s NYSE Debut Cements First-Mover Advantage in Post‑Rescheduling U.S. Medical Cannabis, With Texas and Georgia Upside in Focus

Regulatory May 21, 2026 · 08:45

Trulieve Stabilizes Post-Rescheduling Rally as Domestication Vote Looms

Production / Operations May 13, 2026 · 16:30

Trulieve swaps Canadian roots for Delaware law, but the home-run catalyst still awaits a rulemaking hearing.

Other May 07, 2026 · 06:15

Trulieve Posts Profit as Cannabis Rescheduling Lifts Margins

Earnings